Aetna to Implement Clinical Collaboration Program in 10 Hospitals by 2025.
ByAinvest
Monday, Sep 22, 2025 7:19 am ET1min read
CVS--
The ACC program has shown promising early results, with 25% of program members actively engaged with an Aetna care manager. This engagement rate is in line with industry benchmarks for successful care management programs [1]. The program's goal is to address the significant healthcare challenge of 20% of Medicare patients being readmitted within 30 days of discharge [1].
Aetna's strategic approach to value-based care and payer-provider collaboration is evident in this initiative. By embedding Aetna nurses directly within hospital settings, the company is creating an integrated care model that bridges the traditional gap between insurers and providers [1]. The program's targeted reduction in 30-day readmissions and hospital length of stay is particularly significant, as each prevented readmission could save $15,000-$20,000 [1].
The expansion to ten hospitals by the end of 2025 includes implementations with AdventHealth Shawnee Mission, Houston Methodist, and WakeMed Health & Hospitals [2]. The ACC program is projected to reduce year-over-year 30-day readmissions and hospital length of stay by five percent once fully implemented at scale [2].
Aetna serves over 4 million Medicare Advantage members, and even modest percentage improvements in readmission rates translate to substantial financial impact [1]. The company plans to continue expanding the ACC program across its network in 2026 and beyond, including for its Commercial business [2].
Aetna's Clinical Collaboration program aims to reduce 30-day readmissions and length of hospital stays by implementing a collaborative care model in ten hospitals by end of 2025. Early indicators show high member engagement and positive results, with implementations underway with AdventHealth Shawnee Mission, Houston Methodist and WakeMed Health & Hospitals.
CVS Health's Aetna (NYSE: CVS) has announced the expansion of its Aetna Clinical Collaboration (ACC) program, aiming to reduce 30-day readmissions and hospital length of stay by 5% year-over-year. The program, which embeds Aetna nurses within hospital staff to support Medicare Advantage members during their hospital discharge and transition process, is being implemented in ten hospitals by the end of 2025 [1].The ACC program has shown promising early results, with 25% of program members actively engaged with an Aetna care manager. This engagement rate is in line with industry benchmarks for successful care management programs [1]. The program's goal is to address the significant healthcare challenge of 20% of Medicare patients being readmitted within 30 days of discharge [1].
Aetna's strategic approach to value-based care and payer-provider collaboration is evident in this initiative. By embedding Aetna nurses directly within hospital settings, the company is creating an integrated care model that bridges the traditional gap between insurers and providers [1]. The program's targeted reduction in 30-day readmissions and hospital length of stay is particularly significant, as each prevented readmission could save $15,000-$20,000 [1].
The expansion to ten hospitals by the end of 2025 includes implementations with AdventHealth Shawnee Mission, Houston Methodist, and WakeMed Health & Hospitals [2]. The ACC program is projected to reduce year-over-year 30-day readmissions and hospital length of stay by five percent once fully implemented at scale [2].
Aetna serves over 4 million Medicare Advantage members, and even modest percentage improvements in readmission rates translate to substantial financial impact [1]. The company plans to continue expanding the ACC program across its network in 2026 and beyond, including for its Commercial business [2].
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet